IgPro — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-06-30 in 8d
ESTIMATED |
READOUT
An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, an
Phase 4 · Primary Immunodeficiency |
CSL Behring | IgPro |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|